ADAMTS16 and gastric cancer: Here, GC patients with high ADAMTS16 expression showed a mean OS of 66 months (95% CI = 55–70 months), while patients with low ADAMTS16 expression presented a mean OS of 96 months (95% CI = 87–105 months).